International Journal for Parasitology-Drugs and Drug Resistance

Papers
(The TQCC of International Journal for Parasitology-Drugs and Drug Resistance is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics53
Heartworm disease – Overview, intervention, and industry perspective50
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa46
Caenorhabditis elegans in anthelmintic research – Old model, new perspectives44
Quantitative benzimidazole resistance and fitness effects of parasitic nematode beta-tubulin alleles43
Anthelmintic resistance in equine nematodes: Current status and emerging trends42
Challenges and opportunities for the adoption of molecular diagnostics for anthelmintic resistance41
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook41
Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa41
Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm40
The molecular basis of antimalarial drug resistance in Plasmodium vivax38
Multiple drug resistance in hookworms infecting greyhound dogs in the USA33
Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions31
Praziquantel use in aquaculture – Current status and emerging issues26
Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs24
The use of ITS-2 rDNA nemabiome metabarcoding to enhance anthelmintic resistance diagnosis and surveillance of ovine gastrointestinal nematodes23
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis22
HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics21
Newly identified parasitic nematode beta-tubulin alleles confer resistance to benzimidazoles21
Spread of anthelmintic resistance in intestinal helminths of dogs and cats is currently less pronounced than in ruminants and horses – Yet it is of major concern20
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma 18
Curcuma longa rhizome extract and Curcumin reduce the adhesion of Acanthamoeba triangularis trophozoites and cysts in polystyrene plastic surface and contact lens18
Focused review: The role of drug combinations for the control of coccidiosis in commercially reared chickens18
Identification of compounds responsible for the anthelmintic effects of chicory (Cichorium intybus) by molecular networking and bio-guided fractionation17
A review study on the anti-trichomonas activities of medicinal plants17
A new paraprobiotic-based treatment for control of Haemonchus contortus in sheep17
Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products16
Treatment of human intestinal cryptosporidiosis: A review of published clinical trials16
MRPA-independent mechanisms of antimony resistance in Leishmania infantum16
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?15
Surveillance of molecular markers of Plasmodium falciparum artemisinin resistance (kelch13 mutations) in Papua New Guinea between 2016 and 201815
Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection14
Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside14
Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside14
Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations14
In vitro and in vivo anti-Cryptosporidium and anti-inflammatory effects of Aloe vera gel in dexamethasone immunosuppressed mice14
Egg reappearance periods of anthelmintics against equine cyathostomins: The state of play revisited14
The ultimate fate determinants of drug induced cell-death mechanisms in Trypanosomatids13
Mefloquine as a prophylaxis for malaria needs to be revisited13
Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs13
The first report of macrocyclic lactone resistant cyathostomins in the UK13
Exploring the β-tubulin gene family in a benzimidazole-resistant Parascaris univalens population13
Mode of action of a formulation containing hydrazones and saponins against leishmania spp. Role in mitochondria, proteases and reinfection process12
Antiplasmodial activity of the natural product compounds alstonine and himbeline12
Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases12
Advances in our understanding of nematode ion channels as potential anthelmintic targets12
Current and emerging target identification methods for novel antimalarials12
Climate change is likely to increase the development rate of anthelmintic resistance in equine cyathostomins in New Zealand11
Nucleoside analogues for the treatment of animal trypanosomiasis11
Nullscript inhibits Cryptosporidium and Toxoplasma growth11
Schistosome TRP channels: An appraisal11
Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni11
Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters11
In vitro activity of Camellia sinensis (green tea) against trophozoites and cysts of Acanthamoeba castellanii11
0.013489961624146